PHARMACOKINETICS OF HUMAN IMMUNOGLOBULIN G, 10%, ADMINISTERED INTRAVENOUSLY (IGIV), SUBCUTANEOUSLY (IGSC) OR FACILITATED SUBCUTANEOUSLY WITH RECOMBINANT HUMAN HYALURONIDASE (IGHY) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES

被引：0
|
作者：
Wasserman, R. L. [1 ]
Melamed, I. [2 ]
Stein, M. [3 ]
Rubinstein, A. [4 ,5 ]
Puck, J. [6 ]
Gupta, S. [7 ]
Engl, W. [8 ]
Leibl, H. [8 ]
McCoy, B. [8 ]
Gelmont, D. [9 ]
Schiff, R. I. [9 ]
机构：
[1] DallasAllergyImmunology, Dallas, TX USA
[2] IMMUNOe, Centennial, CO USA
[3] Allergy Associates Palm Beaches, N Palm Beach, FL USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Montefiore Hosp, Bronx, NY USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Univ Calif Irvine, Irvine, CA USA
[8] Baxter BioSci, Vienna, Austria
[9] Baxter BioSci, Westlake Village, CA USA
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2012年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [21] LONG-TERM TOLERABILITY AND SAFETY OF FACILITATED-SUBCUTANEOUS INFUSION OF HUMAN IMMUNOGLOBULIN G, 10%, AND RECOMBINANT HUMAN HYALURONIDASE: A PHASE 3 EXTENSION STUDY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
    Melamed, Isaac
    Wasserman, Richard L.
    Stein, Mark
    Rubinstein, Arye
    Puck, Jennifer
    Gupta, Sudhir
    Engl, Werner
    Leibl, Heinz
    Yel, Leman
    Schiff, Richard I.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 727 - 728
  • [22] Efficacy Analysis of Subcutaneous Immune Globulin (HUMAN), 10 % (SCIG 10 %) Administered Intravenously or Subcutaneously in Patients with Primary Immunodeficiency Diseases (PIDD)
    Wasserman, Richard L.
    Kobrynski, Lisa
    Stein, Mark
    Engl, Werner
    Berner, Todd
    Leibl, Heinz
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S55 - S55
  • [23] Tolerability and Efficacy of Facilitated-Subcutaneous Infusion of Immune Globulin (Human), 10% and Recombinant Human Hyaluronidase (Ighy) In Patients With Primary Immunodeficiency (Pi)
    Stein, Mark
    Wasserman, Richard
    Melamed, Isaac
    Rubinstein, Arye
    Engl, Werner
    Leibl, Heinz
    McCoy, Barbara
    Gelmont, David
    Schiff, Richard
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 354 - 354
  • [24] EFFECT OF SUBCUTANEOUSLY ADMINISTERED HUMAN RECOMBINANT ERYTHROPOIETIN ON ERYTHROPOIESIS IN PATIENTS WITH MYELODYSPLASIA
    VANKAMP, H
    PRINSZEPOSTEMA, TC
    KLUIN, PM
    DENOTTOLANDER, GJ
    BEVERSTOCK, GC
    WILLEMZE, R
    FIBBE, WE
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (04) : 488 - 493
  • [25] Tolerability and Pharmacokinetic Properties of Ondansetron Administered Subcutaneously With Recombinant Human Hyaluronidase in Minipigs and Healthy Volunteers
    Dychter, Samuel S.
    Harrigan, Rena
    Bahn, Jesse D.
    Printz, Marie A.
    Sugarman, Barry J.
    DeNoia, Emanuel
    Haughey, David B.
    Fellows, Daniel
    Maneval, Daniel C.
    CLINICAL THERAPEUTICS, 2014, 36 (02) : 211 - 224
  • [26] Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IgG) (IGHy) in Patients with Primary Immunodeficiency Disease (PIDD): Infections over Time
    Wasserman, Richard L.
    Stein, Mark R.
    Kobrynski, Lisa J.
    Gupta, Sudhir
    Grant, J. Andrew
    Rubinstein, Arye
    Rabbat, Christopher J.
    Engl, Werner
    McCoy, Barbara
    Leibl, Heinz
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB219 - AB219
  • [27] Real-World Use of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IG) (IGHy) in Patients with Primary Immunodeficiency Disorders (PIDD)
    Rosenbach, Kevin P.
    Hughes, Stephanie
    Rozen, Leon
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB220 - AB220
  • [28] LONG-TERM SAFETY AND PHARMACOKINETICS OF FACILITATED-SUBCUTANEOUS INFUSION OF HUMAN IMMUNE GLOBULIN G, 10%, AND RECOMBINANT HUMAN HYALURONIDASE: PHASE 3 EXTENSION STUDY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
    Melamed, I.
    Wasserman, R.
    Stein, M. R.
    Rubinstein, A.
    Puck, J.
    Gupta, S.
    Engl, W.
    Leibl, H.
    Gelmont, D. M.
    Schiff, R. I.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A98 - A99
  • [29] Safety and Pharmacokinetics of Facilitated-Subcutaneous Infusion of Immune Globulin (Human), 10% and Recombinant Human Hyaluronidase (IGHy) in a Phase III Extension Study in Patients With Primary Immunodeficiency Disease (PIDD)
    Melamed, I.
    Wasserman, R. L.
    Stein, M.
    Puck, J.
    Gupta, S.
    Engl, W.
    Leibl, H.
    Gelmont, D.
    Schiff, R. I.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB203 - AB203
  • [30] A clinical trial protocol to evaluate the safety and pharmacokinetics of subcutaneously administered immunoglobulin in patients with primary immunodeficiency
    Vong, Linda
    LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS, 2019, 6 (02): : 75 - 86
12345